الف) فارسی
- ابراهیمی، شهرام و دانش، مصطفی (1398)، «تحلیل شکلی و ماهوی قانون مبارزه با قاچاق کالا و ارز»، مطالعات حقوق کیفری و جرمشناسی ،ش 2، دورۀ پاییز و زمستان.
- بیابانی، غلامحسین و نظری، غلامحسین (1391)، «بررسی ابعاد قاچاق کالا و روشهای مبارزه با آن»، دوفصلنامۀ بررسیهای حقوقی، ش 3، دورۀ بهار و تابستان.
- پایگاه خبری- تحلیلی فرارو (1397)، «پروتز تقلبی در ستون فقرات بیماران واقعی»، 27 بهمن 1397، کد خبر: 390932 ، به آدرس:https://fararu.com/fa/news/390932 : آخرین بازدید 12 آذر ماه 1399.
- توکلی، احمدرضا و حقشناس، محمدرضا (1393)، «جرائم علیه سلامت عمومی از منظر فقه مقارن و حقوق جزا با تأکید بر جرم تقلب در کالاهای خوراکی»، دوفصلنامۀ فقه مقارن، ش 3، دورۀ بهار و تابستان.
- جاوید، احسان و نیاورانی، صابر (1392)، « قلمرو حق سلامتی در نظام بینالمللی حقوق بشر»، فصلنامۀ پژوهش حقوق عمومی، ش 41، دورۀ پاییز.
- دیدهبان شفافیت و عدالت- اخبار دیدهبان (1398)، «پروندههای فساد ... »، 13 مرداد 1398، به آدرس: 2019/08/04 http://daad.ir : آخرین بازدید 12 آذر 1399.
- 7. عباسی، محمود؛ رضایی، راحله؛ دهقانی، غزاله (1393)، «مفهوم و جایگاه حق بر سلامت در نظام حقوقی ایران»، فصلنامۀ حقوق پزشکی، ش30، دورۀ پاییز.
- متقی، سمیرا؛ سیفی، آناهیتا؛ درودیان، مجید (1396)، «ماهیت حق بر سلامت و جایگاه دولت در تحقق آن»، پژوهشنامۀ حقوق اسلامی، ش 2 (پیاپی 46)، دورۀ پاییز و زمستان.
- نظریۀ مشورتی شمارۀ 376/94/7 ادارۀ کل حقوقی قوۀ قضائیه، 14/2/1394.
- نظریۀ مشورتی شمارۀ 316/93/7 ادارۀ کل حقوقی قوۀ قضائیه، 15/2/1393.
ب) خارجی
- Abiri, Armaghan (2018), A critical analysis of the reform of the pharmaceutical sector in Iran, with specific reference to the regulatory framework, PhD thesis, Southern Cross University, Lismore.
- Abbing, Henriette D.C. Roscam (2018), “European Governance of Health Systems. It Takes Two to Tango: The Council of Europe and the European Union”, European Journal of health law, 2018, Vol. 25, Issue. 2, pp. 121-131
- Altavilla, Annagrazia (2018), Safe, “Innovative and Accessible Medicines in Europe: A Renewed Strategy for Patients and the Pharmaceutical Sector”,European Journal of Health Law, Vol. 25 , pp. 133-156.
- Alwon ,Bassam Mohammad (2015), Developing a national strategy for combating counterfeit medicines, thesis, School of Pharmacy ,University of East Anglia.
- Ambos, Kai (2018), European Criminal Law,United Kingdom,Cambridge university press .
- Attaran, Amir (2015), “Stopping Murder by Medicine: Introducing the Model Law on Medicine Crime”, The American Journal of Tropical Medicine and Hygiene , Vol. 92 (Suppl 6), pp. 127–132.
- Attaran,Amir; Bate, Roger; Megan, Dall (2011), “Why and How to Make an International Crime of Medicine Counterfeiting “ , Journal of International Criminal Justice, Vol. 9, pp. 325-354.
- Babar, Zaheer-Ud-Din (2017), Pharmaceutical Policy in Countries with Developing Healthcare Systems, Springer International Publishing AG, Cham.
- Bate ,Roger ; Attaran, Amir (2010), “A Counterfeit Drug Treaty: Great Idea, Wrong Implementation “,The Lancet, Vol. 376, No. 9751, pp. 1446-1448.
- Buckley, Gillian J. and Gostin, Lawrence O.(2013), Countering the Problem of Falsified and Substandard Drugs, Washington, D.C., the National Academies Press.
- Calderoni, Francesco (2010), Organized Crime Legislation in the European Union, Berlin Heidelberg, Springer.
- Card, Richard (2006), Criminal Law, 17 ed., New York, Oxford University Press.
- Casabona, Carlos M. Romeo; Mora, Asier Urruela; Jiménez, Pilar Nicolás; Jiménez. Óscar Alarcón (2017), “International strategies in fighting against medicaments fraud and other similar offences,The MEDICRIME Convention”, Crime Law and Social Change,68, Issue. 1-2, pp. 95-122.
- Chika,A; Bello, SO; Jimoh, AO;Umar, MT (2011), “The menace of fake drugs: consequences, causes and possible solutions”, Research Journal of Medical Sciences ,Vol. 5, Issue. 5 , pp. 257-261.
- Council of Europe (2015), Handbook For Parliamentarians (MEDICRIME Convention, CETS No. 211), Strasbourg, Council of Europe .Avilable at:20/06/2020: https://www.edqm.eu/sites/default/files/handbook-for-parliamentarians-medicrime.pdf
- Council of Europe (CoE), Explanatory Report to the Council of Europe Convention on Laundering, Search, Seizure and Confiscation of the Proceeds from Crime and on the Financing of Terrorism, Strasbourg , Council of Europe, Treaty Office. Avilable at: 20/06/2020: https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=09000016800d3813
- Council of Europe (CoE)(2012) Explanatory Report to the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health, Strasbourg , Council of Europe ,Treaty Office. Avilable at: 20/06/2020: https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=09000016800d383b
- Council of Europe ,Treaty Office- Chart of signatures and ratifications of Treaty 211 ( Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health )
Status as of 20/03/2020. Avilable at: 04/04/2020:
https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/211/signatures? p_auth=8kLrbMfB
- Cvetanovski, Filip; Brezovska ,Katerina; Panovska, Ana Poceva; Acevska, Jelena; Ribarska, Jasmina Tonic; Sterjev, Zoran; Grozdanova, Aleksandra; Netkovska, Katerina Ancevska (2016), “Counterfeiting of medicines as an infringement of the intellectual property rights”, Macedonian pharmaceutical bulletin, Vol. 62, Issue. 1, pp. 85-89.
- Dégardin, Klara; Roggo, Yves; Margot, Pierre (2014), “Understanding and fighting the medicine counterfeit market”, Journal of Pharmaceutical and Biomedical Analysis, 87, pp. 167-175.
- European Commission (2017), Handbook on How to Issue and Execute a European Arrest Warrant, Brussels, 28.9.2017 C(2017) 6389 final, Available at : 16.08.2109
https://e-justice.europa.eu/fileDownload.do?id=db28c045-9f92-472e-9452-518b4ce84712
- European Directorate for the Quality of Medicines & HealthCare (EDQM)(2018), the Edqm on the Move, Annual Report, Strasbourg, Council of Europe, Available at: 16.01.2020: https://www.edqm.eu/sites/default/files/medias/fichiers/AboutUs/annual_report_2018.pdf
- European Medicines Agency ( 2015), European Medicines Agency: Celebrating 20 Years (1995-2005), The editors: Sir Kent Woods & Pharm. Noël Wathion ,Designed & Published by Core Media Services UK Ltd. & Service Point.
- European Parlement (2012), Everything you need to know about ACTA, Focus, Directorate for the Media ,Director - Spokesperson: Jaume DUCH GUILLOT, Reference No:20120220FCS38611. Available at: 11.01.2020
https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//NONSGML+IM- PRESS+20120220FCS38611+0+DOC+PDF+V0//EN&language=EN
- Fayzrakhmanov, N.F.(2015), “Fighting trafficking of falsified and substandard medicinal products in Russia”, International Journal of Risk & Safety in Medicine,Vol. 27, pp. 37–40.
- Gadinis, Stavros; Mangels, Colby (2016), “Collaborative Gatekeepers”, Washington and Lee Law Review, Vol. 73, Issue. 2, pp. 797-914
- Hamilton, William L; Doyle ,Cormac, Halliwell-Ewen, Mycroft;Gabriel ,Lambert (2016), “Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies”, Health Policy and Planning, Vol. 31, No. 10, pp.1448-1466.
- IMPACT (2006), Counterfeit Medicines: an update on estimates 15 November 2006, World Health Organization. Available at: (08.01.2020)
https://www.interpol.int/en/News-and-Events/News/2019/Operation-Pangea-shining-a-light-on-pharmaceutical-crime
- Isles , Mike (2017), “What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate”,Medicines Access @ Point of Care, Vol. 1, pp. 40-48.
- Jalili ,Ronak; Miraghaei, Shahram; Mohamadi, Bahareh; Babaei, Atefeh; Bahrami, Gholamreza ( 2015), “Detection of corticosteroid compounds and phosphodiester inhibitors (PDH-5) as counterfeit in herbal products available in Iranian market by HPLC method”, Journal of Reports in Pharmaceutical Sciences, 2015, Vol. 4, Issue. 1, pp.75-81.
- Johansson, Monika; Fransson ,Dick; Rundlöf ,Torgny ; Huynh ,Ngoc-Hang; Arvidsson , Torbjörn (2014). “A general analytical platform and strategy in search for illegal drugs”, Journal of Pharmaceutical and Biomedical Analysis ,100, pp. 215–229.
- Keitel,Susanne (2012), “The MEDICRIME Convention: criminalizing the falsification of medicines and similar crimes”, Generics and Biosimilars Initiative Journal, Vol. 1, Issue. 3-4, pp. 138-141
- Kohli ,Vishv Priya (2018), Combatting Falsification and Counterfeiting of Medicinal Products in the European Union - A Legal Analysis, Doctoral School Of Business And Management,Copenhagen Business School.
- Le, Phuong; Grund, Laurie; Marwa, John; Ojo ,Wuraola; Otts Jr., John; Arab, Farhia (2018), “Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain: The Drug Supply Chain Security Act (DSCSA) of 2013”, Innovations In Pharmacy,Vol. 9, No. 2, Article. 13, pp. 1-11.
- Lee ,Kah Seng ; Yee ,Siew Mei; Razi Zaidi , Syed Tabish; Patel , Rahul P. ; Yang, Quan ; Al-Worafi ,Yaser Mohammed and Ming, Long Chiau (2017). “Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle”, Frontiers in Pharmacology,Vol. 8 , pp. 1-4.
- Liberman , Jonathan (2012 ), “Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance”, journal of law, medicine & ethics, Vol. 40, Issue. 2, pp. 326-347.
- Mackey,Timothy Ken (2014), Global Governance and Diplomacy Solutions for Counterfeit Medicines, PhD thesis, San Diego,University of California, San Diego State University.
- Mydin , Helmy Haja; Stevens, Philip (2013), fake medicine in Asia, EMHN BRIEFING No.1, The Institute for Democracy and Economic Affairs Institute, Avilable at 20/10/2019: https://www.researchgate.net/profile/Helmy_Haja_Mydin/publication/235912758_Fake_medicines_in_Asia/links/02bfe51410e45883f2000000/Fake-medicines-in-Asia.pdf
- Nayyar, Gaurvika M. L.; Attaran ,Amir; Clark, John P.; Culzoni , M. Julia; Fernandez, Facundo M.; Herrington, James E.; Kendall, Megan; Newton, Paul N.; Breman, Joel G. (2015), “Responding to the Pandemic of Falsified Medicines”, The American Journal of Tropical Medicine and Hygiene ,Vol. 92 (Suppl 6), pp. 113–118
- Negri ,Stefania (2016), “The Medicrime Convention Combating Pharmaceutical Crimes through”.
European Criminal Law and Beyond”, New Journal of European Criminal Law, Vol. 7, Issue. 3, pp. 350-367.
- Newton,Paul N.; Green, Michael D; Fernandez, Facundo M. (2010), “Impact of poor-quality medicines in the ‘developing’ world”, Trends in Pharmacological Sciences,Vol. 31, No. 3, pp. 99-101.
- O’Hagan, Andrew ; Garlington , April (2018), “Counterfeit drugs and the online pharmaceutical trade, a threat to public safety”, Forensic Research & Criminology International Journal, Vol. 6, No. 3 , pp. 151-158 .
- Parliamentary Assembely - Report Committee on Economic Affairs and Development Rapporteur (2007), Need for a Council of Europe convention on the suppression of counterfeiting and trafficking in counterfeit goods , Doc. 11227, Available at: 16.08.2109
http://www.assembly.coe.int/nw/xml/XRef/X2H-Xref-ViewHTML.asp?FileID=11474&Lang=EN
- Pashkov,Vitalii; Soloviov,Aleksey; Olefir, Andrii (2017), “Legal Aspects Of Counteracting The Trafficking Of Falsified Medicines In The European Union”, Wiad Lek, 71, 4, pp. 843-849.
- Rebiere, Hervé; Guinot ,Pauline; Chauvey, Denis; Brenier, Charlotte (2017), “Fighting falsified medicines: The analytical approach”, Journal of Pharmaceutical and Biomedical Analysis ,Vol. 142 , pp. 286–306.
- The lancet (2011), Fighting fake drugs: the role of WHO and pharma, Elsevier,p.1. Available at: (08.01.2020)
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(11)60656-9.pdf
- Valverde, José Luis (2017), “Illegal medicines as threats to public health”, Pharmaceuticals Policy and Law, 19, pp. 1–16.
- Vermeulen , G.; Beken, T. Vander (1997), “New Conventions on Extradition in the European Union: Analysis and Evaluation”, Penn State International Law Review , Vol. 15: No. 2, pp. 265-300.
- Warman, Matt (2012), “European Parliament rejects ACTA piracy treaty”, The Telegraph, Available at: (08.01.2020)
https://www.telegraph.co.uk/technology/news/9375822/European-Parliament-rejects-ACTA-piracy-treaty.html
- World Health Organization- Department of Essential Drugs and Other Medicines Counterfeit Drugs (1999), Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs, Switzerland, World Health Organization.
- World Health Organization (2018), WHO Global Surveillance and Monitoring System for substandard and falsified medical products, Switzerland, World Health Organization.
- World Health Organization (2017), WHO Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products , Switzerland , World Health Organization.
- World Health Organization (2017), WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices, Geneva, World Health Organization.
- World Health Organization (2006), “Fact sheet N°275, Counterfeit Medicines”, Available at: (27.08.2019) www.who.int/mediacentre/factsheets/fs275/en/print.html
|